Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × AZD9833 × 90 days × Clear all

Phase

Phase 3 2 Phase 1/2 2 Phase 2 1 Phase 1 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 131 Specimen Handling 130 Cyclophosphamide 122 Magnetic Resonance Spectroscopy 104 Biopsy 93 fludarabine 89 Nivolumab 64 Carboplatin 50 venetoclax 47 Paclitaxel 45 Gemcitabine 45 fludarabine phosphate 41 Cisplatin 41 Radiotherapy 38 Ipilimumab 36 Cetuximab 35 atezolizumab 34 Bevacizumab 34 Fluorouracil 33 Dexamethasone 32 Oxaliplatin 27 Injections 26 Azacitidine 26 durvalumab 25 Leucovorin 25 Cytarabine 25 Radiation 24 Irinotecan 24 X-Rays 23 Radiosurgery 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03616587 2026-01-28

SERENA-1

AstraZeneca

Phase 1 Active not recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡